Evidence map›Paper›PMID 27580824›Full record

ArticleScientific reports2016

Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β.

Yi-Jheng Peng, Jing-Jia Huang, Hao-Han Wu, Hsin-Ying Hsieh, Chia-Ying Wu, Shu-Ching Chen, Tsung-Yu Chen, Chih-Yung Tang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Restoration of Shal/KCellular and molecular life sciences : CMLS · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Skeletal muscle ClC-1 chloride channels in health and diseases.Pflugers Archiv : European journal of physiology · 2020
    Review
  8. Pathomechanisms of aFrontiers in neurology · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yi-Jheng PengDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jing-Jia HuangDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hao-Han WuDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hsin-Ying HsiehDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chia-Ying WuDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Shu-Ching ChenDepartment of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Tsung-Yu ChenNeuroscience Center, University of California, Davis, USA.
Chih-Yung TangDepartment of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TWUniversity of California, Davis · US

Funding

Molecular Physiology of CLC Chloride ChannelsR01GM065447 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEN, TSUNG-YU · 2003 to 2018
$3.9M
NIGMS NIH HHS R01 GM065447
6 · The paper itself

Abstract

Mutations in human CLC-1 chloride channel are associated with the skeletal muscle disorder myotonia congenita. The disease-causing mutant A531V manifests enhanced proteasomal degradation of CLC-1. We recently found that CLC-1 degradation is mediated by cullin 4 ubiquitin ligase complex. It is currently unclear how quality control and protein degradation systems coordinate with each other to process the biosynthesis of CLC-1. Herein we aim to ascertain the molecular nature of the protein quality control system for CLC-1. We identified three CLC-1-interacting proteins that are well-known heat shock protein 90 (Hsp90)-associated co-chaperones: FK506-binding protein 8 (FKBP8), activator of Hsp90 ATPase homolog 1 (Aha1), and Hsp70/Hsp90 organizing protein (HOP). These co-chaperones promote both the protein level and the functional expression of CLC-1 wild-type and A531V mutant. CLC-1 biosynthesis is also facilitated by the molecular chaperones Hsc70 and Hsp90β. The protein stability of CLC-1 is notably increased by FKBP8 and the Hsp90β inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) that substantially suppresses cullin 4 expression. We further confirmed that cullin 4 may interact with Hsp90β and FKBP8. Our data are consistent with the idea that FKBP8 and Hsp90β play an essential role in the late phase of CLC-1 quality control by dynamically coordinating protein folding and degradation.

Indexed as

Chloride ChannelsCullin ProteinsCysteine Proteinase InhibitorsGene Expression RegulationGenetic VectorsHEK293 CellsHomeodomain ProteinsHSP90 Heat-Shock ProteinsHumansLentivirusLeupeptinsModels, BiologicalMolecular ChaperonesMyotonia CongenitaPatch-Clamp TechniquesProteasome Endopeptidase ComplexAHSA1 protein, humanbenzyloxycarbonylleucyl-leucyl-leucine aldehydeChloride ChannelsCLC-1 channelCUL4A protein, humanCullin ProteinsCysteine Proteinase InhibitorsFKBP8 protein, humanHomeodomain ProteinsHOPX protein, humanHSP90AB1 protein, humanHSP90 Heat-Shock ProteinsLeupeptinsMolecular ChaperonesProteasome Endopeptidase ComplexRNA, Small InterferingTacrolimus Binding ProteinsTumor Suppressor Proteins

Identifiers

PMID27580824
PMCPMC5007535
OpenAlexW2516779580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.